HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G SHUTTING DOWN THREE MANUFACTURING FACILITIES

This article was originally published in The Rose Sheet

Executive Summary

P&G SHUTTING DOWN THREE MANUFACTURING FACILITIES and shifting some production lines at four additional plants over the next 30 months, the firm announced May 19. The closures, which include a health and beauty care products manufacturing plant in Hatboro, PA, a pharmaceuticals factory in Manati, Puerto Rico and a throat drop manufacturing facility in Torshalla, Sweden, are part of a major manufacturing restructuring program announced by Proctor and Gamble in July ("The Rose Sheet" July 19, p. 5.). The program, expected to save $500 mil. after taxes by fiscal 1996, will cut a total of 6,500 jobs and approximately 30 manufacturing plants.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000474

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel